Clinical trial
Minimally Invasive Treatment of Pilonidal Sinus Disease: Which is Better? Phenol or Laser Ablation
NCT06721169 is registered in ClinicalTrials.gov with Mersin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimally Invasive Treatment of Pilonidal Sinus Disease: Which is Better? Phenol or Laser Ablation
- Lead sponsor
- Mersin University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 28, 2024
- Completion date
- November 15, 2026
- Enrollment
- 64 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pilonidal sinus disorder, pilonidal sinus treatment, surgical outcomes